Aminomethanobenzazocine intermediates
N-Alkylated-8-aminated-2,6-methano-3-benzazocines, useful as strong analgesics, are prepared by one route comprising reduction of 8-nitro intermediates or by another route comprising Birch type reduction of 8-methoxy intermediates followed by dehydration-rearrangement of the oximes of the resulting 8-oxo intermediates.
Claims
Referenced Cited
U.S. Patent Documents
| 3632591 | January 1972 | Albertson et al. |
| 3764606 | October 1973 | Akkerman et al. |
| 3853889 | December 1974 | Monkovic et al. |
| 4009171 | February 22, 1977 | Albertson |
Patent History
Patent number: RE29943
Type: Grant
Filed: Aug 22, 1977
Date of Patent: Mar 20, 1979
Assignee: Sterling Drug Inc. (New York, NY)
Inventors: Mark P. Wentland (North Greenbush, NY), Noel F. Albertson (Schodack, NY)
Primary Examiner: Natalie Trousof
Assistant Examiner: Richard A. Schwartz
Attorneys: Theodore C. Miller, B. Woodrow Wyatt
Application Number: 5/826,683
Type: Grant
Filed: Aug 22, 1977
Date of Patent: Mar 20, 1979
Assignee: Sterling Drug Inc. (New York, NY)
Inventors: Mark P. Wentland (North Greenbush, NY), Noel F. Albertson (Schodack, NY)
Primary Examiner: Natalie Trousof
Assistant Examiner: Richard A. Schwartz
Attorneys: Theodore C. Miller, B. Woodrow Wyatt
Application Number: 5/826,683
Classifications
Current U.S. Class:
Two Of The Cyclos Share At Least Three Ring Carbons (e.g., Benzomorphans, Etc.) (546/97);
424/267
International Classification: C07D22126;
International Classification: C07D22126;